Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-19

Clinical Trial Update: Fluid Chloride and AKI in Cardiopulmonary Bypass [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating whether fluid chloride content affects acute kidney injury during cardiopulmonary bypass.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of New Mexico | Conditions: Acute Kidney Injury | Phase 2 | Status: COMPLETED | Results posted: 2018-03-19